Literature DB >> 18768850

Contrasting responses of lymphoid progenitors to canonical and noncanonical Wnt signals.

Sachin Malhotra1, Yoshihiro Baba, Karla P Garrett, Frank J T Staal, Rachel Gerstein, Paul W Kincade.   

Abstract

The Wnt family of secreted glycoproteins has been implicated in many aspects of development, but its contribution to blood cell formation is controversial. We overexpressed Wnt3a, Wnt5a, and Dickkopf 1 in stromal cells from osteopetrotic mice and used them in coculture experiments with highly enriched stem and progenitor cells. The objective was to learn whether and how particular stages of B lymphopoiesis are responsive to these Wnt family ligands. We found that canonical Wnt signaling, through Wnt3a, inhibited B and plasmacytoid dendritic cell, but not conventional dendritic cell development. Wnt5a, which can oppose canonical signaling or act through a different pathway, increased B lymphopoiesis. Responsiveness to both Wnt ligands diminished with time in culture and stage of development. That is, only hematopoietic stem cells and very primitive progenitors were affected. Although Wnt3a promoted retention of hematopoietic stem cell markers, cell yields and dye dilution experiments indicated it was not a growth stimulus. Other results suggest that lineage instability results from canonical Wnt signaling. Lymphoid progenitors rapidly down-regulated RAG-1, and some acquired stem cell-staining characteristics as well as myeloid and erythroid potential when exposed to Wnt3a-producing stromal cells. We conclude that at least two Wnt ligands can differentially regulate early events in B lymphopoiesis, affecting entry and progression in distinct differentiation lineages.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18768850      PMCID: PMC2562264          DOI: 10.4049/jimmunol.181.6.3955

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  59 in total

1.  A role for Wnt signalling in self-renewal of haematopoietic stem cells.

Authors:  Tannishtha Reya; Andrew W Duncan; Laurie Ailles; Jos Domen; David C Scherer; Karl Willert; Lindsay Hintz; Roel Nusse; Irving L Weissman
Journal:  Nature       Date:  2003-04-27       Impact factor: 49.962

2.  Transcription from the RAG1 locus marks the earliest lymphocyte progenitors in bone marrow.

Authors:  Hideya Igarashi; Sophia C Gregory; Takafumi Yokota; Nobuo Sakaguchi; Paul W Kincade
Journal:  Immunity       Date:  2002-08       Impact factor: 31.745

3.  Wnt target genes identified by DNA microarrays in immature CD34+ thymocytes regulate proliferation and cell adhesion.

Authors:  Frank J T Staal; Floor Weerkamp; Miranda R M Baert; Caroline M M van den Burg; Mascha van Noort; Edwin F E de Haas; Jacques J M van Dongen
Journal:  J Immunol       Date:  2004-01-15       Impact factor: 5.422

4.  Wnt proteins are lipid-modified and can act as stem cell growth factors.

Authors:  Karl Willert; Jeffrey D Brown; Esther Danenberg; Andrew W Duncan; Irving L Weissman; Tannishtha Reya; John R Yates; Roel Nusse
Journal:  Nature       Date:  2003-04-27       Impact factor: 49.962

5.  Wnt5a inhibits B cell proliferation and functions as a tumor suppressor in hematopoietic tissue.

Authors:  Huiling Liang; Qin Chen; Andrew H Coles; Stephen J Anderson; German Pihan; Allan Bradley; Rachel Gerstein; Roland Jurecic; Stephen N Jones
Journal:  Cancer Cell       Date:  2003-11       Impact factor: 31.743

6.  Loss of beta-catenin impairs the renewal of normal and CML stem cells in vivo.

Authors:  Chen Zhao; Jordan Blum; Alan Chen; Hyog Young Kwon; Seung Hye Jung; J Michael Cook; Anand Lagoo; Tannishtha Reya
Journal:  Cancer Cell       Date:  2007-12       Impact factor: 31.743

7.  Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor.

Authors:  Noboru Sato; Laurent Meijer; Leandros Skaltsounis; Paul Greengard; Ali H Brivanlou
Journal:  Nat Med       Date:  2003-12-21       Impact factor: 53.440

8.  beta-Catenin expression enhances generation of mature thymocytes.

Authors:  Thomas Mulroy; Youyuan Xu; Jyoti Misra Sen
Journal:  Int Immunol       Date:  2003-12       Impact factor: 4.823

9.  Wnt-5a inhibits the canonical Wnt pathway by promoting GSK-3-independent beta-catenin degradation.

Authors:  Lilia Topol; Xueyuan Jiang; Hosoon Choi; Lisa Garrett-Beal; Peter J Carolan; Yingzi Yang
Journal:  J Cell Biol       Date:  2003-09-01       Impact factor: 10.539

10.  Beta-catenin is dispensable for hematopoiesis and lymphopoiesis.

Authors:  Monica Cobas; Anne Wilson; Bettina Ernst; Stéphane J C Mancini; H Robson MacDonald; Rolf Kemler; Freddy Radtke
Journal:  J Exp Med       Date:  2004-01-12       Impact factor: 14.307

View more
  37 in total

1.  ROR1 is expressed on hematogones (non-neoplastic human B-lymphocyte precursors) and a minority of precursor-B acute lymphoblastic leukemia.

Authors:  H Elizabeth Broome; Laura Z Rassenti; Huan-You Wang; Lilly M Meyer; Thomas J Kipps
Journal:  Leuk Res       Date:  2011-08-02       Impact factor: 3.156

2.  WNT5A: a motility-promoting factor in Hodgkin lymphoma.

Authors:  F Linke; S Zaunig; M M Nietert; F von Bonin; S Lutz; C Dullin; P Janovská; T Beissbarth; F Alves; W Klapper; V Bryja; T Pukrop; L Trümper; J Wilting; D Kube
Journal:  Oncogene       Date:  2016-06-06       Impact factor: 9.867

3.  Wnt/β-catenin signaling regulates proliferation of human cornea epithelial stem/progenitor cells.

Authors:  Martin N Nakatsu; Zhenhua Ding; Madelena Y Ng; Thuy T Truong; Fei Yu; Sophie X Deng
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-07-01       Impact factor: 4.799

4.  Canonical Wnt signaling promotes pacemaker cell specification of cardiac mesodermal cells derived from mouse and human embryonic stem cells.

Authors:  Wenbin Liang; Pengcheng Han; Elizabeth H Kim; Jordan Mak; Rui Zhang; Angelo G Torrente; Joshua I Goldhaber; Eduardo Marbán; Hee Cheol Cho
Journal:  Stem Cells       Date:  2019-12-30       Impact factor: 6.277

Review 5.  Wnt signaling in normal and malignant hematopoiesis.

Authors:  William Lento; Kendra Congdon; Carlijn Voermans; Marcie Kritzik; Tannishtha Reya
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-02-01       Impact factor: 10.005

6.  CD86 is expressed on murine hematopoietic stem cells and denotes lymphopoietic potential.

Authors:  Tomoyuki Shimazu; Ryuji Iida; Qingzhao Zhang; Robert S Welner; Kay L Medina; José Alberola-Lla; Paul W Kincade
Journal:  Blood       Date:  2012-02-27       Impact factor: 22.113

Review 7.  Early B lymphocyte development: Similarities and differences in human and mouse.

Authors:  Michiko Ichii; Kenji Oritani; Yuzuru Kanakura
Journal:  World J Stem Cells       Date:  2014-09-26       Impact factor: 5.326

Review 8.  Wnt Signaling: Role in Regulation of Haematopoiesis.

Authors:  Ram Babu Undi; Usha Gutti; Itishri Sahu; Shilpa Sarvothaman; Satya Ratan Pasupuleti; Ravinder Kandi; Ravi Kumar Gutti
Journal:  Indian J Hematol Blood Transfus       Date:  2015-08-28       Impact factor: 0.900

9.  Absence of sclerostin adversely affects B-cell survival.

Authors:  Corey J Cain; Randell Rueda; Bryce McLelland; Nicole M Collette; Gabriela G Loots; Jennifer O Manilay
Journal:  J Bone Miner Res       Date:  2012-07       Impact factor: 6.741

10.  Asynchronous RAG-1 expression during B lymphopoiesis.

Authors:  Robert S Welner; Brandt L Esplin; Karla P Garrett; Rosana Pelayo; Hervé Luche; Hans Jörg Fehling; Paul W Kincade
Journal:  J Immunol       Date:  2009-12-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.